EyePoint Pharmaceuticals
EYPT
EYPT
74 hedge funds and large institutions have $103M invested in EyePoint Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
13% less funds holding
Funds holding: 85 → 74 (-11)
35% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 26
57% less capital invested
Capital invested by funds: $237M → $103M (-$135M)
Holders
74
Holding in Top 10
2
Calls
$277K
Puts
$73K
Top Buyers
| 1 | +$1.15M | |
| 2 | +$928K | |
| 3 | +$576K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$420K |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$400K |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$3.88M | |
| 3 | -$1.78M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.74M |
| 5 |
O
OrbiMed
New York
|
-$1.69M |